Evidence used
- No CISA KEV confirmation is currently recorded.
- A structured source references public exploit or proof-of-concept material.
- EPSS is 19.61% for the current model date.
BlackTreeCVE IntelligenceUnknown · Unknown
High technical severity with public exploit material referenced by a structured source; prioritise exposed affected systems while verifying vendor guidance.
High technical severity with public exploit material referenced by a structured source; prioritise exposed affected systems while verifying vendor guidance.
Fix not verifiedLinear eMerge E3-Series devices allow Privilege Escalation.
Linear eMerge E3-Series devices allow Privilege Escalation.
The application performs an authorisation check, but it does not correctly enforce the required permission boundary.
An attacker operating through a network path may attempt exploitation with low privileges. If successful, the issue may gain additional privileges.
Linear eMerge E3-Series devices allow Privilege Escalation.
The application performs an authorisation check, but it does not correctly enforce the required permission boundary.
An attacker operating through a network path may attempt exploitation with low privileges. If successful, the issue may gain additional privileges.
CVSS severity, EPSS forecast probability, public exploit material and CISA-confirmed exploitation are separate signals.
No CISA KEV match was present at the last successful refresh. This means no confirmation from that source, not proof of no exploitation.
A structured CVE source labels at least one public reference as exploit material. BlackTree has not independently validated that it is safe, reliable or weaponised.
CWE-863: Incorrect Authorization. The product performs an authorization check when an actor attempts to access a resource or perform an action, but it does not correctly perform the check.
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:HCommon Vulnerability Scoring System 3.1: the compact vector below is decoded into plain language.
Operational remediation based on structured source evidence.
Published 2 Jul 2019 · Last source change 4 Aug 2024, 20:46 UTC · CWE-863 · Incorrect Authorization
Missing structured fields: affected product. Missing data is not evidence of low risk; review the primary advisory.